Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
There is no population for whom use of this compound is supported by evidence
Almost done We sent the first email to
Designed by Peptides Web Design
In phase II trials focusing on dermal applications, TB-500 has displayed promising outcomes for patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa
While many of the findings cited above were observed in animal studies (and therefore cannot be extrapolated to humans), there is evidence that researchers are actively exploring BCP-157s potential in these areas
US$ 29.72
US$ 22.05
US$ 21.87
US$ 22.79
